Head-to-head · WeighScore
Garcia Weight Loss, Aesthetics & Hormone Therapy vs Zealthy
The verdict
Garcia Weight Loss, Aesthetics & Hormone Therapy takes it — 59.4/100 to 46.7/100.
Garcia Weight Loss, Aesthetics & Hormone Therapy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established Tampa Bay medical weight-loss clinic operating since 2000 with four Florida locations.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Garcia Weight Loss, Aesthetics & Hormone Therapy | Zealthy |
|---|---|---|
| WeighScore | 59.4/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #342 | #496 |
| Semaglutide | $400/mo (starting dose, compounded) | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | 1 state | 34 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #342 · C
Strengths
- Established since 2000 with 4 Tampa Bay locations and 50,000+ patients treated
- GLP-1 program includes full metabolic and hormone lab panel
- Medication and supplies shipped directly to your door from partner pharmacy
- Free 15-minute consultation; both weekly-visit (Premier) and monthly-visit (Standard) tiers
- LegitScript transparency certification listed in footer
Where it loses points
- Florida only — 4 locations in Tampa Bay metro area only
- Pricing not publicly listed on website ($400/month per Facebook ad)
- Specific GLP-1 drug (semaglutide vs tirzepatide) not disclosed on site
- Telemedicine availability not confirmed on site despite Facebook ad claims
- In-person visit model less convenient than fully online telehealth providers
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.